SCA2 presenting as a focal dystonia.

Nan Cheng, Heather M Wied, James J Gaul, Lauren E Doyle, Stephen G Reich
{"title":"SCA2 presenting as a focal dystonia.","authors":"Nan Cheng,&nbsp;Heather M Wied,&nbsp;James J Gaul,&nbsp;Lauren E Doyle,&nbsp;Stephen G Reich","doi":"10.1186/s40734-018-0073-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Spinocerebellar ataxia 2 (SCA2) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansions in <i>ATXN2</i> on chromosome 12q24. Patients present with adult-onset progressive gait ataxia, slow saccades, nystagmus, dysarthria and peripheral neuropathy. Dystonia is known to occur as SCA2 advances, but is rarely the presenting symptom.</p><p><strong>Case presentation: </strong>A 43-year-old right handed woman presented with focal dystonia of the right hand which started two years earlier with difficulty writing. There were only mild cerebellar signs. Her mother was reported to have a progressive gait disorder and we subsequently learned that she had SCA2. A total of 10 maternal family members were similarly affected. Over the course of 10 years, the patient's cerebellar signs progressed only mildly however the dystonia worsened to the extent of inability to use her right hand. Dystonia did not improve significantly with botulinum toxin, levodopa or trihexyphenidyl, but has shown marked improvement since DBS implantation in the GPi.</p><p><strong>Conclusions: </strong>We describe a patient with SCA2 who presented with focal dystonia of the right upper extremity. Subtle cerebellar signs as well as the family history became especially important given the absence of predominant gait ataxia. Our case emphasizes that focal dystonia is not only a feature of SCA2, but can also rarely be the presenting sign as well as the most prominent feature during the disease course.</p>","PeriodicalId":15374,"journal":{"name":"Journal of Clinical Movement Disorders","volume":"5 ","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40734-018-0073-7","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Movement Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40734-018-0073-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Spinocerebellar ataxia 2 (SCA2) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansions in ATXN2 on chromosome 12q24. Patients present with adult-onset progressive gait ataxia, slow saccades, nystagmus, dysarthria and peripheral neuropathy. Dystonia is known to occur as SCA2 advances, but is rarely the presenting symptom.

Case presentation: A 43-year-old right handed woman presented with focal dystonia of the right hand which started two years earlier with difficulty writing. There were only mild cerebellar signs. Her mother was reported to have a progressive gait disorder and we subsequently learned that she had SCA2. A total of 10 maternal family members were similarly affected. Over the course of 10 years, the patient's cerebellar signs progressed only mildly however the dystonia worsened to the extent of inability to use her right hand. Dystonia did not improve significantly with botulinum toxin, levodopa or trihexyphenidyl, but has shown marked improvement since DBS implantation in the GPi.

Conclusions: We describe a patient with SCA2 who presented with focal dystonia of the right upper extremity. Subtle cerebellar signs as well as the family history became especially important given the absence of predominant gait ataxia. Our case emphasizes that focal dystonia is not only a feature of SCA2, but can also rarely be the presenting sign as well as the most prominent feature during the disease course.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SCA2表现为局灶性肌张力障碍。
背景:脊髓角性共济失调2型(SCA2)是一种常染色体显性遗传的神经退行性疾病,由染色体12q24上ATXN2的CAG重复扩增引起。患者表现为成人发作的进行性步态共济失调、缓慢扫视、眼球震颤、构音障碍和周围神经病变。众所周知,肌张力障碍会随着SCA2的进展而发生,但很少是表现症状。病例介绍:一名43岁的右手女性出现局灶性右手肌张力障碍,两年前开始时书写困难。只有轻微的小脑症状。据报道,她的母亲患有进行性步态障碍,随后我们得知她患有SCA2。共有10名产妇家庭成员受到类似影响。在10年的过程中,患者的小脑体征进展缓慢,但肌张力障碍恶化到无法使用右手的程度。肉毒杆菌毒素、左旋多巴或苯尼三己基酯并没有显著改善肌张力障碍,但自DBS植入GPi以来,肌张力障碍已显示出显著改善。结论:我们描述了一名SCA2患者,其表现为右上肢局灶性肌张力障碍。由于没有主要的步态共济失调,微妙的小脑体征以及家族史变得尤为重要。我们的病例强调,局灶性肌张力障碍不仅是SCA2的一个特征,而且很少是疾病过程中最突出的症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson's disease patient. Video-based long-term follow up of musician’s dystonia in pianists reveals similar improvements following different treatment strategies: a retrospective observational study AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles. Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic. Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1